These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 12494279

  • 1. Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus.
    Vickers MA, Satyanarayana R.
    Int J Impot Res; 2002 Dec; 14(6):466-71. PubMed ID: 12494279
    [Abstract] [Full Text] [Related]

  • 2. Phosphodiesterase 5 inhibitors for erectile dysfunction.
    Setter SM, Iltz JL, Fincham JE, Campbell RK, Baker DE.
    Ann Pharmacother; 2005 Dec; 39(7-8):1286-95. PubMed ID: 15941818
    [Abstract] [Full Text] [Related]

  • 3. Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature.
    Gresser U, Gleiter CH.
    Eur J Med Res; 2002 Oct 29; 7(10):435-46. PubMed ID: 12435622
    [Abstract] [Full Text] [Related]

  • 4. Oral drug treatment of erectile dysfunction.
    Int J Impot Res; 2003 Dec 29; 15 Suppl 7():S27-9. PubMed ID: 14695970
    [No Abstract] [Full Text] [Related]

  • 5. PDE-5 inhibitors: current status and future trends.
    Masson P, Lambert SM, Brown M, Shabsigh R.
    Urol Clin North Am; 2005 Nov 29; 32(4):511-25, viii. PubMed ID: 16291042
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Drug Insight: oral phosphodiesterase type 5 inhibitors for erectile dysfunction.
    Briganti A, Salonia A, Gallina A, Saccà A, Montorsi P, Rigatti P, Montorsi F.
    Nat Clin Pract Urol; 2005 May 29; 2(5):239-47. PubMed ID: 16474835
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New phosphodiesterase type 5 inhibitors in the management of erectile dysfunction.
    Mason RG.
    J R Soc Promot Health; 2003 Jun 29; 123(2):79-80. PubMed ID: 12852189
    [No Abstract] [Full Text] [Related]

  • 14. Phosphodiesterase 5 inhibitors in male sexual dysfunction.
    Kuthe A.
    Curr Opin Urol; 2003 Sep 29; 13(5):405-10. PubMed ID: 12917517
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Vardenafil treatment for erectile dysfunction.
    Crowe SM, Streetman DS.
    Ann Pharmacother; 2004 Jan 29; 38(1):77-85. PubMed ID: 14742800
    [Abstract] [Full Text] [Related]

  • 18. Vardenafil 20-mg demonstrated superior efficacy to 10-mg in Japanese men with diabetes mellitus suffering from erectile dysfunction.
    Ishii N, Nagao K, Fujikawa K, Tachibana T, Iwamoto Y, Kamidono S.
    Int J Urol; 2006 Aug 29; 13(8):1066-72. PubMed ID: 16903931
    [Abstract] [Full Text] [Related]

  • 19. Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: a randomized prospective study.
    Ghofrani HA, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadaş B, Schermuly RT, Weissmann N, Seeger W, Grimminger F.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1488-96. PubMed ID: 15464333
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.